What does next-generation sequencing mean for prenatal diagnosis?

被引:11
作者
Manegold-Brauer, Gwendolin [1 ]
Hahn, Sinuhe [2 ]
Lapaire, Olav [1 ]
机构
[1] Univ Basel, Ultrasound Unit, Dept Gynecol & Obstet, CH-4003 Basel, Switzerland
[2] Univ Basel, Dept Biomed, Lab Prenatal Med, CH-4003 Basel, Switzerland
关键词
cell-free DNA; cell-free fetal DNA; massive parallel genomic sequencing; noninvasive prenatal testing; CELL-FREE DNA; MATERNAL PLASMA; FETAL DNA; DOWN-SYNDROME; GENETIC AMNIOCENTESIS; CHROMOSOMES; 13; TRISOMIES; 21; ANEUPLOIDY; BLOOD; RISK;
D O I
10.2217/bmm.14.18
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The ability to gain genetic information from the fetus in the mother's blood during pregnancy has been a long desired goal of research in prenatal medicine. The detection of fetal DNA in maternal blood, coupled with the development of the powerful techniques of next-generation sequencing finally transferred this analysis into clinical practice. Following the commercial introduction of noninvasive prenatal testing for aneuploidies, there has been a very strong demand, which has fostered an extreme rapid development and improvement of technology. Publications in this field are so numerous so that it is challenging to keep up with the latest state of the art. Here, we describe the current basic concepts of cell-free DNA-based noninvasive prenatal testing, give an overview of the currently commercially available tests and the chromosomal aberrations that can be identified. We also present current and future concepts for the implementation of cell-free DNA testing into clinical care.
引用
收藏
页码:499 / 508
页数:10
相关论文
共 80 条
[1]   Commercial landscape of noninvasive prenatal testing in the United States [J].
Agarwal, Ashwin ;
Sayres, Lauren C. ;
Cho, Mildred K. ;
Cook-Deegan, Robert ;
Chandrasekharan, Subhashini .
PRENATAL DIAGNOSIS, 2013, 33 (06) :521-531
[2]   Genomic testing reaches into the womb [J].
Allison, Malorye .
NATURE BIOTECHNOLOGY, 2013, 31 (07) :595-601
[3]  
American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459
[4]   Noninvasive Prenatal Testing for Fetal Aneuploidy [J].
不详 .
OBSTETRICS AND GYNECOLOGY, 2012, 120 (06) :1532-1534
[5]   Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method [J].
Ashoor, G. ;
Syngelaki, A. ;
Wang, E. ;
Struble, C. ;
Oliphant, A. ;
Song, K. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (01) :21-25
[6]   Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18 [J].
Ashoor, Ghalia ;
Syngelaki, Argyro ;
Wagner, Marion ;
Birdir, Cahit ;
Nicolaides, Kypros H. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (04) :322.e1-322.e5
[7]   Non-invasive prenatal testing for aneuploidy: current status and future prospects [J].
Benn, P. ;
Cuckle, H. ;
Pergament, E. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (01) :15-33
[8]   Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis [J].
Benn, Peter ;
Borell, Antoni ;
Chiu, Rossa ;
Cuckle, Howard ;
Dugoff, Lorraine ;
Faas, Brigitte ;
Gross, Susan ;
Johnson, Joann ;
Maymon, Ron ;
Norton, Mary ;
Odibo, Anthony ;
Schielen, Peter ;
Spencer, Kevin ;
Huang, Tianhua ;
Wright, Dave ;
Yaron, Yuval .
PRENATAL DIAGNOSIS, 2013, 33 (07) :622-629
[9]   At-home fetal DNA gender testing - Caveat emptor [J].
Bianchi, Diana W. .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (02) :216-218
[10]   Integration of Noninvasive DNA Testing for Aneuploidy into Prenatal Care: What Has Happened Since the Rubber Met the Road? [J].
Bianchi, Diana W. ;
Wilkins-Haug, Louise .
CLINICAL CHEMISTRY, 2014, 60 (01) :78-87